Cargando…
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
Both targeted therapy and immunotherapy have been used successfully to treat melanoma, but the development of resistance and poor response rates to the individual therapies has limited their success. Designing rational combinations of targeted therapy and immunotherapy may overcome these obstacles,...
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361951/ https://www.ncbi.nlm.nih.gov/pubmed/30718660 http://dx.doi.org/10.1038/s41598-018-37883-y |